secwatch.observer — SEC 8-K summary
======================================

Issuer:     AN2 Therapeutics, Inc. (ANTX)
CIK:        0001880438
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001193125-25-143187
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AN2 Therapeutics exchanges 2.8M common shares for pre-funded warrants with Coastlands Capital
--------------------------------------------------------------------------------

- Exchanged 2,500,000 shares of common stock for pre-funded warrant for 2,500,000 shares on June 17, 2025.
- Exchanged additional 300,000 shares for pre-funded warrant for 300,000 shares on June 19, 2025.
- Warrants have $0.00001 exercise price, no expiration, and beneficial ownership blocker at 9.99% (up to 19.99%).
- Issued under Section 3(a)(9) exemption from registration; form of warrant filed as Exhibit 4.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1880438/000119312525143187/0001193125-25-143187-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1880438/000119312525143187/d50241d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-143187

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer